A new drug, Tivicay, that could be vital in the struggle against HIV, might not be available to those who need it the most.
The new bird flu strain that has killed 36 people has proved resistant to Tamiflu for the first time, a development scientists find "concerning".
According to data, by 2016 pharmaceutical spending in Africa is expected to reach $30-billion - driven by the continent's increasing economic wealth.
Cervical cancer is caused by a very common virus, but it is easy to detect and there is a vaccination for it, writes Mia Malan
A new book detailing how profit-hungry pharmaceutical companies mislead medical practitioners and harm patients may be just what the doctor ordered.
GlaxoSmithKline has been fined $3-billion after admitting to encouraging the prescription of unsuitable antidepressants to children.
But experts warn that drugs alone will not win it, after the pharmaceutical giants agree to work together on an ambitious project.
Diseases with little or no symptoms are silently killing South Africans.
Exclusively breastfed babies are less likely to become obese adults, research has shown.
Virus samples will be shared globally in exchange for vaccines produced from them under a landmark deal to improve preparedness for a flu pandemic.
Leading UK and international organisations have written to Britain's largest drug company urging it to pool its patents on HIV medicines.
There is no evidence of a link between weight loss drug Xenical and liver injury, drugmaker Roche said on Tuesday.
Bill Gates and thousands of babies are helping Africa prepare its largest medical experiment ever in the search for a new vaccine against malaria.
Three British bankers whose extradition to the United States caused a political storm last year are on the brink of a plea agreement that could involve an admission of wrongdoing over an alleged $20-million fraud related to the collapse of Enron.
A malaria vaccine currently under development can be safely given to young infants and appears to offer strong protection against the disease, according to the results of a study conducted in Mozambique. The finding clears the way for final-stage testing of GlaxoSmithKline's vaccine, known as Mosquirix.